
Tema Oncology ETF
CANCNASDAQTemaEquity
As of Nov 16, 2026 close
- Assets (AUM)
- $206.87M
- Expense ratio
- 0.75%
- Dividend yield
- 0.05%
- Holdings
- 58
- 52-week range
- $33.25$47.00
- Volume (live)
- -
- Avg. volume (3M)
- 18.71K
CANC ETF: Tema Oncology ETF - Price, Holdings & Analysis
Tema Oncology ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $40.16 - $41.48 |
|---|---|
| 52-Week High | $47.00 |
| 52-Week Low | $33.25 |
| Open | $41.48 |
| Volume (last close) | 17.99K |
| Average Volume (3M) | 18.71K |
| 1 Day Change | −1.95% |
|---|---|
| 1 Month Change | +1.55% |
| 6 Month Change | +8.56% |
| YTD Change | +16.40% |
| 1 Year Change | +19.88% |
| Annual Dividend | $0.02 |
|---|---|
| Dividend Yield | 0.05% |
| Last Dividend Ex-Date | Dec 10, 2025 |
| Dividend Growth YoY | −97.31% |
| Assets (AUM) | $206.87M |
|---|---|
| Expense Ratio | 0.75% |
| Total Holdings | 58 |
| Inception Date | Aug 14, 2023 |
| 50-Day MA | $41.48 |
|---|---|
| 200-Day MA | $39.56 |
| RSI | 42.54 |
| Stochastic %K | 2.90 |
| Stochastic %D | 13.62 |
Source: Exchange price data and fund disclosures. Data as of Nov 16, 2026. Data sources and methodology
CANC at a Glance
Tema Oncology ETF (CANC) is an equity ETF from Tema, launched in August 2023. It manages $206.87M in assets and charges a 0.75% expense ratio, about $75 a year per $10,000 invested.
Based on holdings data updated Nov 14, 2026, it holds 58 positions. The largest are Genmab A/S (GMAB, 5.92%), Eli Lilly and Company (LLY, 5.43%) and Revolution Medicines, Inc. (RVMD, 5.43%). The top 10 holdings make up 44.9% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (76.6%), Switzerland (11.4%) and Denmark (5.9%).
It pays distributions yielding 0.05% at the Nov 16, 2026 close, $0.02 per share over the trailing 12 months. As of the Nov 16, 2026 close, the share price is up 19.9% over one year (price change, excluding distributions).
Frequently Asked Questions About Tema Oncology ETF
What is the current price of CANC?
The latest CANC price is $40.26 (Nov 16, 2026 close). The 52-week range is $33.25–$47.00. The share price is up 19.9% over the past year (price change, excluding distributions).
What is the expense ratio for CANC?
CANC's annual expense ratio is 0.75%, about $75 a year for every $10,000 invested.
Does CANC pay dividends?
Yes, CANC pays a 0.05% dividend yield (trailing 12 months, at the Nov 16, 2026 close). The most recent ex-dividend date was December 10, 2025. View full dividend history in the Dividends section.
What are the top holdings of CANC?
In holdings data last updated Nov 14, 2026, CANC's largest holdings are Genmab A/S (5.9%), Eli Lilly and Company (5.4%), Revolution Medicines, Inc. (5.4%) (combined weight: 16.8%). The fund holds 58 total positions. View the complete portfolio breakdown in the Holdings section.
How concentrated is CANC's portfolio?
In holdings data updated Nov 14, 2026, the top 10 holdings make up 44.9% of CANC's assets across 58 positions. Its largest sector weight is Healthcare at 100.0%.
How large is CANC and when did it launch?
CANC manages $206.87M in assets. Tema launched the fund on August 14, 2023, about 3 years before the Nov 16, 2026 close.